Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
George Town, Grand Cayman, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Theravance Biopharma, Inc. has filed 1,125 SEC EDGAR filings since 01 Aug 2013

SEC filing history

Showing 851-875 of 1,000 matching filings.

Per page
25
Current page
35
4

FORM 4 -

Filing date
08 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
08 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
08 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88552

SC 13D/A filing

Filing date
03 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SC 13G/A filing

Filing date
27 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36033

8-K

Filing date
09 Jan 2017
Reporting date
09 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36033

CT ORDER filing

Filing date
23 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Nov 2016
Reporting date
20 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Nov 2016
Reporting date
20 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Nov 2016
Reporting date
20 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Nov 2016
Reporting date
20 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Nov 2016
Reporting date
20 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Nov 2016
Reporting date
20 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Nov 2016
Reporting date
20 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Nov 2016
Reporting date
20 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36033

8-K

Filing date
14 Nov 2016
Reporting date
14 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88552

SC 13G filing

Filing date
10 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36033

8-K

Filing date
08 Nov 2016
Reporting date
08 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36033

8-K

Filing date
02 Nov 2016
Reporting date
27 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214257

424B5

Filing date
31 Oct 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214257

424B5

Filing date
31 Oct 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-214257

FWP

Filing date
28 Oct 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214257

424B5

Filing date
26 Oct 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214257

424B5

Filing date
26 Oct 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .